Penny Stocks

With a current absence of company-specific news for Lottery.com, investor attention has shifted to the broader market environment for digital...

The clinical development pipeline at Avenue Therapeutics is progressing, with recent strategic moves placing several drug candidates in the spotlight....

The investment community is closely monitoring Outlook Therapeutics as it navigates a decisive period for its flagship ophthalmic drug. While...

Following a strategic realignment, IntelGenx is now channeling its efforts toward advancing its product pipeline and expanding manufacturing capabilities. The...

Biodexa Pharmaceuticals is laying the groundwork for a pivotal phase in its development, targeting 2026 with a refreshed strategy. The...

Western Magnesium Corporation has taken a significant step forward in its strategy to produce environmentally sustainable magnesium. The company has...

Microvision has taken decisive steps to solidify its financial position and integrate recent acquisitions, announcing a $43 million capital raise...

Longeveron Inc. (NASDAQ: LGVN) is approaching a series of decisive milestones, with 2026 shaping up to be a potentially transformative...

The focus for Remsleep and its investors is undergoing a significant shift. With the regulatory groundwork now firmly established for...

The clinical-stage biotech firm Ensysce Biosciences has entered what many consider the most pivotal period in its development timeline. With...